nCOVID-19: Its diagnosis, possible preventive measures, therapeutic interventions and management

Main Article Content

Mrinal Kanti Poddar*
Apala Chakraborty

Abstract

Novel coronavirus (nCOVID-19) is a current global threat causing severe infections to millions of people throughout the world. WHO has reported in their case-based surveillance that the aged and male populations are most vulnerable to this recent coronavirus infection. This disease-causing virus, named as SARS-CoV-2, is a respiratory coronavirus that probably originated from the bat with a substantially different genetic makeup concerning the other known coronaviruses. Structurally SARS-CoV-2 is a diverse single-stranded RNA virus having spike (S) glycoprotein in its envelop that is associated with the transmission of the virus by binding with the host target receptor. The principal target site of nCOVID-19 is angiotensin-converting enzyme 2 (ACE2) in the host receptor. The expression of ACE2 target site varies according to the genetic susceptibility and ABO blood group locus causing variation in the severity of the infection. The virus usually affects the inflammatory pathways, responsible for white blood cell activation and clot formation after interacting with pathogen pattern recognition receptors. The major pathological symptoms of severe nCOVID-19 are mild to severe respiratory and bowel syndromes. Prevention of infections has been achieved by social distancing depending on the concept of aerosolized/droplet transmission of virus and by maintaining personal hygiene. Remedies like ayurvedic, homeopathic, micronutrients such as vitamins and minerals along with regular physical exercises like yoga and meditation are also found to be helpful in disease prevention. The treatments that have been applied so far with some positive responses are antimalarial chloroquine and hydroxychloroquine, antivirals, plasma therapy, steroids, omega-3-fatty acid derivatives, vitamin C infusion, etc. Some global healthcare bodies are also in action for the development of vaccines therapy against nCOVID-19. Apart from the infection control, some other associated issues like long term social distancing, constant stress, anxiety, change in lifestyle are affecting adversely the aged populations and also the other part of the society. There is no doubt that government bodies from various countries throughout the world are taking extreme measures to control and mitigate the pandemic, but this untoward situation is still far from the control of human races and supposes to take more time and further scientific interventions and management are needed to be continued.

Downloads

Download data is not yet available.

Article Details

Poddar, M. K., & Chakraborty , A. (2020). nCOVID-19: Its diagnosis, possible preventive measures, therapeutic interventions and management. Archives of Community Medicine and Public Health, 6(2), 115–129. https://doi.org/10.17352/2455-5479.000090
Review Articles

Copyright (c) 2020 Poddar MK, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Su S, Wong G, Shi W, Liu J, Lai A, et al. (2016) Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses Trends in microbiology 24: 490-502. Link: https://bit.ly/3e4jiOE

Zhu N, Zhang D, Wang W, Li X, Yang BA, et al. (2020) Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382: 727-733. Link: https://bit.ly/2CaCDQY

Link: https://bit.ly/2O0JQWt

Link: https://bit.ly/2ZGxPuP

Wu C, Chen X, Cai Y (2020) Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease, 2019 Pneumonia in Wuhan, China JAMA Intern Med Link: https://bit.ly/2VQnkEb

D‟Adamo H, Yoshikawa T, Ouslander JG (2020) Coronavirus Disease 2019 in Geriatrics and Long-term Care: The ABCDs of COVID-19. J Am Geriatr Soc Link: https://bit.ly/3f6nAGS

Zhang L, Ma L, Sun F, Tang Z, Chan P (2020) A Multicenter Study of Multimorbidity in Older Adult In patients in China. J Nutr Health Aging 24: 269-276. Link: https://bit.ly/2NWIfkq

Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, et al. (2020) Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr 51: 102083. Link: https://bit.ly/38ub7tW

Cullen W, Gulati G, Kelly BD (2020) Mental health in the Covid-19 pandemic. QJM pii: hcaa110. Link: https://bit.ly/2ZDbkah

Chakraborty I, Maity P (2020) COVID-19 outbreak: Migration, effects on society, global environment and prevention. Sci Total Environ 728: 138882. Link: https://bit.ly/2W5SOXd .

Mahony JB, Petrich A, Smieja M (2011) Molecular diagnosis of respiratory virus infections. Crit Rev Clin Lab Sci 48: 217‐249. Link: https://bit.ly/3f6nO0G

Azar MM, Landry ML (2018) Detection of influenza A and B viruses and respiratory syncytial virus by use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)waived point‐of‐care assays: a paradigm shift to molecular tests. J Clin Microbiol 56: e00367‐18. Link: https://bit.ly/3goIgKe

Zhang N, Wang L, Deng X, et al. (2020) Recent advances in the detection of respiratory virus infection in humans. J Med ssVirol 92: 408– 417. Link: https://bit.ly/2CbQN4h

Kubo T, Agoh M, Mai LQ, Fukushima K, Yamaguchi A, et al. (2010) Development of a reverse transcription‐loop‐mediated isothermal amplification assay for detection of pandemic (H1N1) 2009 virus as a novel molecular method for diagnosis of pandemic influenza in resource‐limited settings. J Clin Microbiol 48: 728‐735. Link: https://bit.ly/31NJB9B

Zhang P, Vemula SV, Zhao J, Du B, Mohan H, et al. (2014) A highly sensitive europium nanoparticle‐based immunoassay for detection of influenza A/B virus antigen in clinical specimens. J Clin Microbiol 52: 4385‐4387. Link: https://bit.ly/3gsh1P0

Vemula SV, Zhao J, Liu J, Wang X, Biswas S, et al. (2016) Current approaches for diagnosis of influenza virus infections in humans. Viruses 8: 96. Link: https://bit.ly/2DdXxPS

Trombetta VK, Chan YL, Bankowski MJ (2018) Are rapid influenza antigen tests still clinically useful in today's molecular diagnostics world? Hawaii J Med Public Health 77: 226‐230. Link: https://bit.ly/2O0CnqG

Simpson R, Aliyu S, Iturriza‐Gomara M, Desselberger U, Gray J (2003) Infantile viral gastroenteritis: On the way to closing the diagnostic gap. J Med Virol 70: 258‐262. Link: https://bit.ly/2Z1fqtr

Shimada Y, Ariga T, Tagawa Y, Aoki K, Ohno S, et al. (2004) Molecular diagnosis of human adenoviruses D and E by a phylogeny‐based classification method using a partial hexon sequence. J Clin Microbiol 42:1577‐1584. Link: https://bit.ly/2NWIBHM

Madisch I, Wolfel R, Harste G, Pommer H, Heim A (2006) Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol 78: 1210‐1217. Link: https://bit.ly/3iFFpPh

Zhang Q, Jing S, Cheng Z, Yu Z, Dehghan S et al. (2017) Comparative genomic analysis of two emergent human adenovirus type 14 respiratory pathogen isolates in China reveals similar yet divergent genomes. Emerg Microbes Infect 6: e92. Link: https://bit.ly/2C5ueyu

Kim MN, K YJ, Seong MW, Kim JS, Shi BM, et al. (2016) Analytical and clinical validation of six commercial Middle East respiratory syndrome coronavirus RNA detection kits based on real‐time reverse‐transcription PCR. Ann Lab Med 36: 450‐456. Link: https://bit.ly/2YZQ4fJ

Hashemzadeh MS, Rasouli R, Zahraei B, Izadi M, Tat M, et al. (2016) Development of Dual TaqMan based one‐step rRT‐PCR assay panel for rapid and accurate diagnostic test of MERS‐CoV: a novel human coronavirus, ahead of Hajj Pilgrimage. Iran Red Crescent Med J 18: e23874. Link: https://bit.ly/31OnLm4

Go YY, Kim YS, Cheon S, Nam S, Ku KB et al. (2017) Evaluation and clinical validation of two field‐deployable reverse transcription‐insulated isothermal PCR assays for the detection of the Middle East respiratory syndromecoronavirus. J Mol Diagn 19: 817‐827. Link: https://bit.ly/38vGwMw

Shirato K, Semba S, El‐Kafrawy SA, Hassan AM, Tolah AM, et al. (2018) Development of fluorescent reverse transcription loop‐mediated isothermal amplification (RTLAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus. J Virol Methods 258: 41‐48. Link: https://bit.ly/2ZD3u0c

Myatt TA, Johnston SL, Rudnick S, Milton DK (2003) Airborne rhinovirus detection and effect of ultraviolet irradiation on detection by a seminested RT‐PCR assay. BMC Public Health 3: 5. Link: https://bit.ly/2YZR2bS

Do DH, Laus S, Leber A, Marcon MJ, Jordan JA, et al. (2010) A one‐step, real‐time PCR assay for rapid detection of rhinovirus. J Mol Diagn 12: 102‐108. Link: https://bit.ly/2Cau7kW

Schibler M, Yerly S, Vieille G, Docquier M, Turin L, et al. (2012) Critical analysis of rhinovirus RNA load quantification by real‐time reverse transcription‐PCR. J Clin Microbiol 50: 2868‐2872. Link: https://bit.ly/31TWzCN

Slinger R, Milk R, Gaboury I, Diaz‐Mitoma F (2004) Evaluation of the QuickLab RSV test, a new rapid lateral‐flow immunoassay for detection of respiratory syncytial virus antigen. J Clin Microbiol 42: 3731‐3733. Link: https://bit.ly/3f5916d

Borek AP, Clemens SH, Gaskins VK, Aird DZ, Valsamakis A (2006) Respiratory syncytial virus detection by remel Xpect, Binax Now RSV, direct immunofluorescent staining, and tissue culture. J Clin Microbiol 44: 1105‐1107. Link: https://bit.ly/2NZolW5

Selvarangan R, Abel D, Hamilton M (2008) Comparison of BD Directigen (TM) EZ RSV and Binax NOW (R) RSV tests for rapid detection of respiratory syncytial virus from nasopharyngeal aspirates in a pediatric population. Diagn Microbiol Infec Dis 62: 157‐161. Link: https://bit.ly/2VPe1oa

Lim XF, Lee CB, Pascoe SM, How CB, Chan S et al. (2019) Detection and characterization of a novel bat‐borne coronavirus in Singapore using multiple molecular approaches. J Gen Virol 100: 1363‐1374. Link: https://bit.ly/3f3wkND

Wang N, Luo C, Liu H, Yang X, Hu B, et al. (2019) Characterization of a new member of alphacoronavirus with unique genomic features in rhinolophus bats. Viruses 11: E379. Link: https://bit.ly/2AyyoOX

Huang P, Wang H, Cao Z, Jin H, Chi H, et al. (2018) A rapid and specific assay for the detection of MERS‐CoV. Front Microbiol 9: 1101. Link: https://bit.ly/2Z08ooQ

Cleri DJ, Ricketti AJ, Vernaleo JR (2010) Severe acute respiratory syndrome (SARS) Infect. Dis Clin North Am 24: 175–202. Link: https://bit.ly/3gvOS9L

Guan Y, Zheng B, He Y, Liu X, Zhuang Z, et al. (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science 302: 276-278. Link: https://bit.ly/31NQsji

Woo PCY, Lau SKP, Huang Y, Yuen KY (2009) Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med 234: 1117-1127. Link: https://bit.ly/3grI0dB

Denison MR, Graham RL, Donaldson EF, Eckerle LD, Baric RS (2011) Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity RNA Biol 8: 270-279. Link: https://bit.ly/2ABRLGS

Holmes E (2009) The evolution and emergence of RNA viruses. In Oxford Series in Ecology and Evolution. Edited by Harvey PH, May RM. Oxford University Press Link: https://bit.ly/38sFT6w

Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, et al (2012) Detection of a novel human coronavirus by real‐time reverse‐transcription polymerase chain reaction. Euro Surveill 17: 20185. Link: https://bit.ly/38teQI6

Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel Coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367: 1814‐1820. Link: https://bit.ly/31MzzFv

Hu B, Ge X, Wang LF, Shi Z (2015) Bat origin of human coronaviruses. Virol J 12: 221. Link: https://bit.ly/3iIQqPM

Middle East respiratory syndrome coronavirus (MERS-CoV). WHO. Link: https://bit.ly/2De2BDT

Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, et al. (2020) Systematic comparision of two Animal-to Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses 22: 12. pii: E244. Link: https://bit.ly/3e2yrjF

Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395: 470-473. Link: https://bit.ly/2DdZbB2

Yang Y, Lu Q, Liu M, Wang Y, Zhang A, et al. (2020). Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv Link: https://bit.ly/2VOEv9b

Simmons G, Zmora P, Gierer S, Heurich A, Pöhlmann S (2013) Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res 100: 605–614. Link: https://bit.ly/2ZIBFDB

Li F, Li W, Farzan M, Harrison SC (2005) Structural biology: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309: 1864-1868. Link: https://bit.ly/2YZwnES

Millet JK, Whittaker GR (2015) Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res 202: 120-134. Link: https://bit.ly/3f1eMC4

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, et al. (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Science eabb2507. Link: https://bit.ly/3grIDDZ

Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2002) A NovelAngiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 Circ Res 87: E1–E9. Link: https://bit.ly/2VM7HNR

Zhang H, Kang Z, Gong H, Xu D, Wang J, et al. (2020) The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes bioRxiv 2020.01.30.927806 Link: https://bit.ly/2NXETxV .

Yan R, Zhang Y, Li Y, Xia L, Guo Y, et al. (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 Science 367:1444–1448. Link: https://bit.ly/2NYnEMP

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, et al. (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID- 19) outbreak - an update on the status. Mil Med Res 7: 11. Link: https://bit.ly/3grIG2D

Ou X, Liu Y, Lei X, Li P, Mi D, et al. (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11: 1620. Link: https://go.nature.com/2Z1gLjX

Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli, G, et al. (2020) COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Int J Mol Sci 21: 3474. Link: https://bit.ly/2BzM2ls

Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S (2012) Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol 86: 6537-6545. Link: https://bit.ly/2Z3BNyB

Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R, et al. (2015) Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res 116: 76-84. Link: https://bit.ly/3gy9eiP

Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, et al. (2019) TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. J Virol 93 Link: https://bit.ly/2NVxVcH

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrleer T, et al. (2020) SARSCoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181: 271-280. Link: https://bit.ly/2BxcqMQ

Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, et al. (2013) The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 87: 5502–5511. Link: https://bit.ly/31Pq48K

Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, et al. (2011) Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 85 : 4122–4134. Link: https://bit.ly/38tWp6h

Lan J, Ge J, Yu J, Shan S, Zhou H, et al. (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature Link: https://bit.ly/3gyajXV

Shi Y, Wang Y, Shao C, Huang J, Gan J, et al. (2020) COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27: 1451–1454. Link: https://bit.ly/2VMRGHu

Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A (2020) Genomewide Association Study of Severe Covid-19 with Respiratory Failure. New England Journal of Medicine Link: https://bit.ly/2ABSPKS

Xu Z, Shi L, Wang Y, Zhang J, Huang L, et al. (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory medicine. Link: https://bit.ly/2VOZb0K

Lagunas-Rangel FA, Chávez-Valencia V (2020) High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients. J Med Virol Link: https://bit.ly/2BGoBqv

Canna SW, Behrens EM (2012) Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatric clinics of North America 59: 329–344. Link: https://bit.ly/2DavD7f

Huang C, Wang Y, Li X, Ren L, Zhao J, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497–506. Link: https://bit.ly/2YKFlpn

Qin C, Zhou L, Hu Z, Zhang S, Yang S, et al. (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis Link: https://bit.ly/2BK6dNk

Shi Y, Tan M, Chen X, Yanxia L, Huang J, et al. (2020) Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. medRxiv Link: https://bit.ly/31MYjgV

Zhang B, Zhou X, Zhu C, Feng F, Yanru Q, et al. (2020) Immune phenotyping based on neutrophil- tolymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. Preprint at medRxiv Link: https://bit.ly/2ZJM81X

Chen X, Ling J, Mo P, Zhang Y, Qunqun J, et al. (2020) Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients. Preprint at medRxiv Link: https://bit.ly/2O0BIpa .

Zheng M, Gao Y, Wang G, Goubin S, Liu S, et al. (2020) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol Link: https://bit.ly/3eYmj4q

Shen C, Wang Z, Zhao F (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA Link: https://bit.ly/3ffV45L .

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. (2020) China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med Link: https://bit.ly/2Z4LEnX

Wang YD, Zhang SP, Wei QZ, Zhao MM, Mei H, et al. (2020) COVID-19 complicated with DIC: 2 cases report and literatures review Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi 41: E001. Link: https://bit.ly/2ZEXh3Y

Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost JTH 18: 844-847. Link: https://bit.ly/3e4uX07

Lippi G, Plebani M, Michael Henry B (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 506: 145-148. Link: https://bit.ly/3e6DXlg

Subramaniam S, Scharrer I (2018) Procoagulant activity during viral infections. Front Biosci 23: 1060-1081. Link: https://bit.ly/38sJL7B

van Gorp ECM, Suharti C, ten Cate H, Dolmans WMV, van der Meer JWM, et al. (1999) Review: Infectious Diseases and Coagulation Disorders. J Infect Dis 180: 176-186. 10.1086/314829 Link: https://bit.ly/3gzuvIV

Guo L, Rondina MT (2019) The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases Front. Immunol 10: 2204. Link: https://bit.ly/2Z1i6Y2

Franz-Josef N, Nikolaus M, Meinrad G, Korbinian B, Ilka V, et al. (1997) Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets Circulation, 95 : 2387-2394. Link: https://bit.ly/2Dax1GZ

Xiang P, Xu XM, Gao LL, Wang HZ, Xiong HF, et al. (2020) First case of 2019 novel coronavirus disease with Encephalitis. ChinaXiv T202003:00015.

Anderson EL, Turnham P, Griffin JR, Clarke CC (2020) Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Anal 40: 902-907. Link: doi:10.1111/risa.13500

Bassetti M, Vena A, Giacobbe DR (2020) The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm. Eur J Clin Invest 50: e13209. Link: https://bit.ly/2ZILCAW

Link: https://bit.ly/31NVPis

Xiao F, Tang M, Zheng X, Liu Y, Li X, et al. (2020) Evidence for Gastrointestinal Infection of SARS-CoV-2. 158: 1831-1833. Link: https://bit.ly/2O0EsTu

Carbone F, Bodini G, Brunacci M, Bonaventura A, Vecchiè A, et al. (2018) Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases. Eur J Clin Invest 48: e13002. Link: https://bit.ly/2VN1IIY

Zhang H, Kang Z, Gong H, Xu D (2020) Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process Gut. Link: https://bit.ly/2BxpnGr

Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun S0889-1591: 30465-30467. Link: https://bit.ly/2C83wVW

Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, et al. (2020) Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. Ann Lab Med 40: 351360. Link: https://bit.ly/2ZHcAcs

Link: https://bit.ly/38tjKVw

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, et al. (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25: 2000045. Link: https://bit.ly/3ivfZnc

Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, et al. (2020) Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem pii: hvaa029. Link: https://bit.ly/3iBY8Lh

Link: https://bit.ly/2ObmMVn

Link: https://bit.ly/2BKaOz4 .

Link: https://bit.ly/2ABaaUc

Link: https://bit.ly/2De8pxb

Chen Y, Chen L, Deng Q, Zhang G, Wu K, et al. (2020) The presence of SARS‐CoV‐ 2 RNA in feces of COVID‐ 19 patients. J Med Virol 92: 833-840. Link: https://bit.ly/2VQuZSX

Zhang J, Wang S, Xue Y (2020) Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol 92: 680-682. Link: https://bit.ly/2BJrxCF

Nouri-Vaskeh M, Alizadeh L (2020) Fecal transmission in COVID-19: A potential shedding route. J Med Virol Link: https://bit.ly/2ZEII0n

Jiang X, Luo M, Zou Z, Wang X, Chen C, et al. (2020) Asymptomatic SARS‐CoV‐2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days. J Med Virol Link: https://bit.ly/3eYic8x

Link: https://bit.ly/3iFV2pV

Bruning AHL, Leeflang MMG, Vos JMBW, Spijker R, de Jong MD, et al. (2020) Rapid Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review and Meta-analysis. Clin Infect Dis 65: 1026-1032. Link: https://bit.ly/2W69YE7

Liu Y, Liu Y, Diao B, Feifei R, Wang Y, et al. (2020) Diagnostic indexes of a rapid IgG/IgM combined antibody test for SARS-CoV-2. Medxriv Link: https://bit.ly/38tXRp2

Zhang P, Gao Q, Wang T, Ke Y, Mo F, et al. (2020) Evaluation of recombinant nucleocapsid and spice protein serological diagnosis of novel coronavirus disease 2019 (COVID-19). Medxriv. Link: https://bit.ly/3it2vbH

Zhao J, Yuan Q, Wang H, Liu W, Liao X, et al. (2020) Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. medxriv Link: https://bit.ly/31IYQ3w

Okba NMA, Muller MA, Li W, Wang C, Corine H, et al. (2020) SARS-COV-2 specific antibody responses in COVID-19 patients. medxriv Link: https://bit.ly/31IYQ3w

Wölfel R, Corman V, Guggemos W, Seilmaier M, Mueller M, et al. (2020) Virological assessment of hospitalized patients with COVID-2019. Nature Link: https://go.nature.com/31MPzrd

Wang N, Li SY, Yang XL, Huang HM, Zhang YJ, et al. (2018) Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China. Virol Sin 33: 104-107. doi:10.1007/s12250-018-0012-7 Link: https://bit.ly/3iAGyaw

Che XY, Qiu LW, Liao ZY, Wang YD, Wen K, et al. (2005) Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. The Journal of Infectious Diseases 191: 2033–2037 Link: https://bit.ly/2Z3JmFi

Diagnosis and Treatment Protocol for COVID-19. Link: https://bit.ly/31QQM0y

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, et al. (2020) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res 7: 4 Link: https://bit.ly/2Z2jVUX

Home care for patients with suspected novel coronavirus (‎‎‎‎‎‎‎‎‎‎‎nCoV)‎‎‎‎‎‎‎‎‎‎‎ infection presenting with mild symptoms and management of contacts: interim guidance. Link: https://bit.ly/2VLAUZq

Link: https://bit.ly/2ZKulHE

Link: https://bit.ly/2C5HhQu

Link: https://bit.ly/2C6nErm

Link: https://bit.ly/38CcsyT

Falkenberg RI, Eising C, Peters ML (2018) Yoga and immune system functioning: a systematic review of randomized controlled trials. J Behav Med 41: 467-482. Link: https://bit.ly/31UTsds

Link: https://bit.ly/38uoWZm

Bracho G, Varela E, Fernández R, Ordaz B, Marzoa N, et al. (2010) Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control. Homeopathy 99: 156-166. Link: https://bit.ly/3gw6YbH

Link: https://bit.ly/38uoWZm

Link: https://bit.ly/2ZHepWB

Thurnham DI (1997) Micronutrients and immune function: some recent developments. J Clin Pathol 50: 887-891. Link: https://bit.ly/31PwlkG

Chandra RK (1992) Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 340:1124-1127. Link: https://bit.ly/38u805j

Muscogiuri G, Barrea L, Savastano S, Colao A (2020) Nutritional recommendations for COVID-19 quarantine. Eur J Clin Nutr Link: https://bit.ly/2Z0kZs8

Te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, et al. (2010) Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 6: e1001176. Link: https://bit.ly/31RKspB

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. Link: https://bit.ly/2Z366W6

Zhou D, Dai SM, Tong Q (2020) COVID-19:a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother 75: 1667-1670. Link: https://bit.ly/2Z1spLI

Devaux CA, Rolain JM, Colson P, Raoult D (2020) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents 55: 105938. Link: https://bit.ly/3idoCTb

Yao X, Ye F, Zhang M, Cui C, Huang B, et al. (2020) In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. Link: https://bit.ly/3gp2gwi

Inglot AD (1969) Comparison of the antiviral activity in vitro of some non-steroidal antiinflammatory drugs. J Gen Virol 4: 203-214. Link: https://bit.ly/2VN9ySA

Miller DK, Lenard J (1981) Antihistaminics, local anesthetics, and other amines as antiviral agents. Proc Natl Acad Sci U S A 78: 3605-3609. Link: https://bit.ly/3gq3fw8

Silva JA, Silva MB, Skare TL (2007) Chloroquine and QTc interval. Clin Exp Rheumatol 25: 795. Link: https://bit.ly/3gs0TNx

Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents Link: https://bit.ly/3fg6qGV

Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, et al. (2020) Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Netw Open 3: e208857. Link: https://bit.ly/3gwBMcs

Chu C, Cheng V, Hung I, Wong M, Chan K, et al. (2004) Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59: 252-256. Link: https://bit.ly/38xeVuv

de Wilde AH, Jochmans D, Posthuma CC, Zevenhoven-Dobbe JC, Nieuwkoop SV, et al. (2014) Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother 58: 4875-4884. Link: https://bit.ly/2BKnaHs

Dong L, Hu S, Gao J (2020) Discovering drugs to treat coronavirus disease 2019 (COVID19) Drug Discov Ther 14: 58-60. Link: https://bit.ly/3iDd8J8

Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ (2020) A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option J Med Virol 92: 556-563. Link: https://bit.ly/2Z4NEwu

Chan KS, Lai ST, Chu CM, et al. (2003) Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 9: 399-406. Link: https://bit.ly/2O17gem

Link: https://bit.ly/3gutj9t

Cao B, Wang Y, Wen D, Liu W, Wang J, et al. (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 382. Link: https://bit.ly/2VOWSe9

Report available at: Lopinavir/ritonavir [database online]. Hudson (OH): Lexicomp Inc; 2016. http://online.lexi.com

Stockman LJ, Bellamy R, Garner P (2006) SARS: systematic review of treatment effects. PloS Med 3: e343. Link: https://bit.ly/2DePeTV

Altınbas S, Holmes JA, Altınbas A (2020) Hepatitis C virus infection in pregnancy: an update. Gastroenterol Nurs 43: 12-21. Link: https://bit.ly/2ZEVADJ

Wang D, Hu B, Hu C, Zhu F, Liu X, et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA Link: https://bit.ly/2C47VZT

ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. Link: https://bit.ly/3gwanat

Kadam RU, Wilson IA (2017) Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc Natl Acad Sci U S A 114: 206-214. Link: https://bit.ly/3gs2C5t

Khamitov RA, Loginova SI, Shchukina VN, Borisevich SV, Maksimov VA, et al. (2008) Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures. Vopr Virusol 53: 9-13. Link: https://bit.ly/2BGIsWA

Wang Z, Yang B, Li Q, Wen L, Zhang R (2020) Clinical Features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis Link: https://bit.ly/2VNnxb2

Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, et al. (2017) Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo [2,1-f] [triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses. J Med Chem 60: 1648-1661. Link: https://bit.ly/3f4LulQ

Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93: 449-463. Link: https://bit.ly/2Z2YPFW

Wang M, Cao R, Zhang L, Yang X, Liu J, et al. (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30: 269-271. Link: https://bit.ly/2VLPf8c

Sissoko D, Laouenan C, Folkesson E, M’Lebing AB, Beavogui AH, et al. (2016) Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-ofconcept trial in Guinea PLoS Med 13: e1002009. Link: https://bit.ly/3gtI8cl

Gilead gets EC conditional approval for remdesivir to treat Covid-19. Link: https://bit.ly/2ZEvwIF

Zhang C, Maruggi G, Shan H, Li J (2019) Advances in mRNA vaccines for infectious diseases. Front Immunol 10: 594. Link: https://bit.ly/3f3sTXt

Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, et al. (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 176: 104742. Link: https://bit.ly/3gwkvjv

Link: https://bit.ly/3e2vpfa

Link: https://bit.ly/3e1ltCH

Link: https://bit.ly/2O4R37T

Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, et al. (2004) A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428: 561-564. Link: https://bit.ly/2Z36KTF

Sardesai NY, Weiner DB (2011) Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 23: 421-429. Link: https://bit.ly/3iylgdJ

Link: https://bit.ly/3f2QDe9

Link: https://bit.ly/2ZFoEee

Link: https://bit.ly/2C5szJ8

Link: https://bit.ly/2BFgRoA

Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov 17: 261-279. Link: https://bit.ly/2ZFnDTs

hyFc® Platform. Link: https://bit.ly/3gyCjdZ

Loset GA, Roux KH, Zhu P, Michaelsen TE, Sandlie I (2004) Differential segmental flexibility and reach dictate the antigen binding mode of chimeric IgD and IgM: implications for the function of the B cell receptor. J Immunol 172: 2925-2934. Link: https://bit.ly/2VPyfhz

Link: https://bit.ly/2BxVCoX

Li X, Wang LW, Yang SN, Yang F, Xiang LK, et al. (2020) Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis 94: 128-132. Link: https://bit.ly/2NV5lYO

Zhang B, Zhou X, Qiu Y, Feng F, Feng J, et al. (2020) Clinical characteristics of 82 death cases with COVID-19. medRxi Link: https://bit.ly/31OTgwo

Xie P, Ma W, Tang H, Liu D (2020) Severe COVID-19: A Review of Recent Progress With a Look Toward the Future. Front. Public Health 8: 189. Link: https://bit.ly/2O18J4x

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, et al. (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354: 2564-2575. Link: https://bit.ly/3e3zekv

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, et al. (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315: 801-810. Link: https://bit.ly/38txf7E

Panigrahy D, Gilligan MM, Huang S, et al. (2020) Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev 39: 337-340. Link: https://bit.ly/3gsKGrk

Brenchley JM, Douek DC (2012) Microbial translocation across the GI tract. Annu Rev Immunol 30: 149-173. Link: https://bit.ly/2VRwoIV

Ghosh SS, Wang J, Yannie PJ, Ghosh S (2020) Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocrine Soc 4: bvz039. Link: https://bit.ly/2Z254d3

Gao QY, Chen YX, Fang JY (2020) 2019 Novel coronavirus infection and gastrointestinal tract. J Digestive Dis 21: 125-126. Link: https://bit.ly/2NX3h2m

Owler AA, Truwit JD, Hite RD, Morris PE, DeWilde C, et al. (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis andsevere acute respiratory failure: the CITRIS-ALI randomized clinical trial JAMA 322: 1261-1270. Link: https://bit.ly/3f3OPl3

Carr AC (2020) A new clinical trial to test high-dose vitamin C in patients with COVID19 Crit Care 24: 133 Link: https://bit.ly/2W6kVWf

Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, et al. (2015) The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211: 80-90. Link: https://bit.ly/3f6uonC

Arabi YM, Hajeer AH, Luke T, Raviprakash K, Balkhy H, et al. (2016) Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerg Infect Dis 22: 1554-1561. Link: https://bit.ly/2VOfMBZ

Shen C, Wang Z, Zhao F, Yang Y, Li J, et al. (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323: 1582-1589. Link: https://bit.ly/2ZHwt36

Duan K, Liu B, Li C, Zhang H, Yu T, et al. (2020) Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA117: 9490-9496. Link: https://bit.ly/2C4blvH

Wilson N, Kvalsvig A, Barnard LT, Baker MG (2020) Case-fatality risk estimates for COVID-19 calculated by using a lag time for fatality. Emerg Infect Ids 26: 1339-1441. Link: https://bit.ly/2C8gOli

Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodriguez-Manas L, et al. (2019) Physical frailty: ICFSR International Clinical Practice Guidelines for identification and management. J Nutr Health Aging 23: 771-787. Link: https://bit.ly/2AyQErt

Rodgers M, Dalton J, Harden M, Street A, Parker G, et al. (2018) Integrated care to address the physical health needs of people with severe mental illness: a mapping review of the recent evidence on barriers, facilitators and evaluations. Int J Integr Care18: 9. Link: https://bit.ly/2ZDuNre

Mao L, Wang M, Chen S, He Q, Chang J, et al. (2020) Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. Link: https://bit.ly/3e3SgH6

Sharma S, Sharma M, Singh G (2020) A chaotic and stressed environment for 2019-nCoV suspected, infected and other people in India: Fear of mass destruction and causality. Asian journal of psychiatry51: 102049. Link: https://bit.ly/2C4b0sV

Qiu J, Shen B, Zhao M, Wang Z, Xie B, et al. (2020) A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psych 33: e100213. Link: https://bit.ly/3gtpFgc

Meng H, Xu Y, Dai J, Zhang Y, Liu B, et al. (2020) Analyze the psychological impact of COVID-19 among the elderly population in China and make corresponding suggestions. Psychiatry Res 289: 112983. Link: https://bit.ly/2ZGZ1cT

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, et al. (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet395: 912-920. Link: https://bit.ly/31MlCY7

Gautam R, Sharma M (2020) 2019-nCoV Pandemic: A disruptive and stressful atmosphere for Indian academic fraternity. Brain, behavior and immunity S0889-1591(20)30506-7. Link: https://bit.ly/3f3pxUn

Link: https://bit.ly/2C74O3l

COVID-19 impact will be worse than flu. Link: https://bit.ly/2CdyprK

Ohannessian R, Duong TA, Odone A (2020) Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR public health and surveillance 6: e18810. Link: https://bit.ly/2DaRKuh